{
    "Trade/Device Name(s)": [
        "GSP Neonatal Biotinidase kit"
    ],
    "Submitter Information": "Wallac Oy, a subsidiary of PerkinElmer Inc.",
    "510(k) Number": "K131284",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090123"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NAK"
    ],
    "Summary Letter Date": "November 14, 2013",
    "Summary Letter Received Date": "October 04, 2013",
    "Submission Date": "October 03, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1118"
    ],
    "Regulation Name(s)": [
        "Biotinidase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Biotinidase"
    ],
    "Specimen Type(s)": [
        "Dried blood spot"
    ],
    "Specimen Container(s)": [
        "Filter paper"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Solid phase time-resolved immunofluorescence assay",
        "Eu-labeled biotin substrate",
        "Streptavidin-biotin capture",
        "DELFIA fluorescence detection"
    ],
    "Methodologies": [
        "Enzyme activity measurement",
        "Immunofluorescence"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Reagent",
        "Microtitration plate"
    ],
    "Document Summary": "FDA 510(k) summary for GSP Neonatal Biotinidase kit for quantitative in vitro measurement of biotinidase activity in newborn dried blood spots using automated GSP instrument.",
    "Indications for Use Summary": "Intended for quantitative in vitro determination of human biotinidase activity in dried blood spot specimens as an aid in screening newborns for biotinidase deficiency using the GSP instrument.",
    "fda_folder": "Clinical Chemistry"
}